These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 2836204

  • 21. Comparative evaluation of cardioselectivity of metoprolol OROS and atenolol: a double-blind, placebo-controlled crossover study.
    Tantucci C, Bruni B, Dottorini ML, Peccini F, Motolese M, Lecaillon JB, Sorbini CA, Grassi V.
    Am Heart J; 1990 Aug; 120(2):467-72. PubMed ID: 2200257
    [Abstract] [Full Text] [Related]

  • 22. Effect of beta-blockade on heart rate variability in patients with coronary artery disease.
    Niemelä MJ, Airaksinen KE, Huikuri HV.
    J Am Coll Cardiol; 1994 May; 23(6):1370-7. PubMed ID: 8176095
    [Abstract] [Full Text] [Related]

  • 23. Effects of dilevalol, a beta-adrenoceptor antagonist with intrinsic sympathetic activity in asthmatic patients.
    Hedner J, Ullman A, Lemne C, Svedmyr N.
    Pulm Pharmacol; 1989 May; 2(3):155-9. PubMed ID: 2577692
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G, Berger J, Olsson G, Menzel T.
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Beta-adrenoceptor blockade and hypoglycaemia. A randomised, double-blind, placebo controlled comparison of metoprolol CR, atenolol and propranolol LA in normal subjects.
    Kerr D, MacDonald IA, Heller SR, Tattersall RB.
    Br J Clin Pharmacol; 1990 Jun; 29(6):685-93. PubMed ID: 1974143
    [Abstract] [Full Text] [Related]

  • 33. Metabolic effects of controlled-release metoprolol in hypertensive men with impaired or diabetic glucose tolerance: a comparison with atenolol.
    Fagerberg B, Berglund A, Holme E, Wilhelmsen L, Elmfeldt D.
    J Intern Med; 1990 Jan; 227(1):37-43. PubMed ID: 2405089
    [Abstract] [Full Text] [Related]

  • 34. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ, Kendall MJ.
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [Abstract] [Full Text] [Related]

  • 35. Effect of atenolol, metoprolol, and propranolol on isoproterenol-induced tremor and tachycardia in normal subjects.
    Perucca E, Pickles H, Richens A.
    Clin Pharmacol Ther; 1981 Apr; 29(4):425-33. PubMed ID: 6258838
    [Abstract] [Full Text] [Related]

  • 36. Treatment with beta-blockers--the value of an even plasma concentration over 24 h.
    Agewall S, Kendall M.
    J Clin Pharm Ther; 1997 Jun; 22(3):171-9. PubMed ID: 9447471
    [Abstract] [Full Text] [Related]

  • 37. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E, Ostergren J, Lindvall K, Dahlöf C, Westergren G, de Faire U.
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [Abstract] [Full Text] [Related]

  • 38. Cardioselectivity of atenolol in asthmatic patients.
    Ellis ME, Sahay JN, Chatterjee SS, Cruickshank JM, Ellis SH.
    Eur J Clin Pharmacol; 1981 Feb; 21(3):173-6. PubMed ID: 7032947
    [Abstract] [Full Text] [Related]

  • 39. A comparison of 100 mg atenolol and 100 mg metoprolol once a day at rest and during exercise in hypertensives.
    Nilsson OR, Atterhög JH, Castenfors J, Jorfelt L, Karlberg BE, Thulin T, Tolagen K, Wettre S, Ohman KP.
    Acta Med Scand; 1984 Feb; 216(3):301-7. PubMed ID: 6388253
    [Abstract] [Full Text] [Related]

  • 40. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P, Moore G, Wieselgren I, Olofsson B, Bergstrand R.
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.